V
Vivek Singh
Researcher at All India Institute of Medical Sciences
Publications - 26
Citations - 383
Vivek Singh is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Virtual screening & Curcumin. The author has an hindex of 10, co-authored 25 publications receiving 266 citations. Previous affiliations of Vivek Singh include Pondicherry University & Nalco Holding Company.
Papers
More filters
Journal ArticleDOI
Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification
Yi Yu Ke,Vivek Singh,Mohane Selvaraj Coumar,Yung Chang Hsu,Wen Chieh Wang,Jen Shin Song,Chun Hwa Chen,Wen-Hsing Lin,Szu Huei Wu,John T.A. Hsu,Chuan Shih,Hsing Pang Hsieh +11 more
TL;DR: Molecular dynamics simulation and density functional theory calculation suggest that BPR056 interacted with FLT3 in a stable manner and could be chemically optimized to realize a drug-like lead in the future.
Journal ArticleDOI
Mechanism of apoptotic induction in human breast cancer cell, MCF-7, by an analog of curcumin in comparison with curcumin – An in vitro and in silico approach
Kumaravel Mohankumar,Sankar Pajaniradje,Subhashree Sridharan,Vivek Singh,Larance Ronsard,Akhil C. Banerjea,Chellakkan Selvanesan Benson,Mohane Selvaraj Coumar,Rukkumani Rajagopalan +8 more
TL;DR: Overall results showed that BDMC-A induced apoptosis more effectively compared to curcumin and the activity can be attributed to the presence of hydroxyl group in the ortho position in its structure.
Journal ArticleDOI
Identification of ligand efficient, fragment-like hits from an HTS library: structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity.
Sailu Sarvagalla,Vivek Singh,Yi Yu Ke,Hui Yi Shiao,Wen-Hsing Lin,Hsing Pang Hsieh,John T.A. Hsu,Mohane Selvaraj Coumar +7 more
TL;DR: In this paper, the authors used ligand efficiency (LE) and ligand-efficiency dependent lipophilicity (LELP) indices to choose fragment-like hits for optimization.
Journal ArticleDOI
Drug repurposing for chronic myeloid leukemia: in silico and in vitro investigation of DrugBank database for allosteric Bcr-Abl inhibitors
Vivek Singh,Hsin Huei Chang,Ching Chuan Kuo,Hui Yi Shiao,Hsing Pang Hsieh,Mohane Selvaraj Coumar +5 more
TL;DR: In this study, structure-based and ligand-based virtual screening methods were applied to narrow down possible drugs that could target the allosteric site of Abl kinase and gefitinib was found to enhance the ability of imatinib to bind at the ATP-binding site of Bcr-Abl kinase.
Journal ArticleDOI
BDMC-A, an analog of curcumin, inhibits markers of invasion, angiogenesis, and metastasis in breast cancer cells via NF-κB pathway--A comparative study with curcumin.
Kumaravel Mohankumar,Subhashree Sridharan,Sankar Pajaniradje,Vivek Singh,Larance Ronsard,Akhil C. Banerjea,Dinesh Babu Somasundaram,Mohane Selvaraj Coumar,Latha Periyasamy,Rukkumani Rajagopalan,Rukkumani Rajagopalan +10 more
TL;DR: Investigation of the inhibitory effects of BDMC-A, an analog of curcumin, on invasion, angiogenesis and metastasis markers using in vitro with MCF-7 cells and in silico studies proved that BD MC-A has more potential thanCurcumin.